These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31006358)

  • 1. Serum substance P and vasoactive intestinal peptide levels in infants with acute intussusception.
    Zhu ZC; Wang HB; Yan XQ; Yang J; Duan XF; Bian HQ; Kuang HF
    J Int Med Res; 2019 Jun; 47(6):2446-2451. PubMed ID: 31006358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basal concentration of Substance P (SP) and Vasoactive Intestinal Peptide (VIP) in the blood serum of children with allergic dermatitis].
    Grzybowska-Chłebowczyk U; Woś H; Szymańska M; Kajor M
    Med Wieku Rozwoj; 2003; 7(1):43-8. PubMed ID: 13130168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do substance P and vasoactive intestinal polypeptide (VIP) play a role in the acute occlusive or chronic ischaemic vasodilation in man?
    Henriksen JH; Bülow JB; Schaffalitzky de Muckadell O; Fahrenkrug J
    Clin Physiol; 1986 Apr; 6(2):163-70. PubMed ID: 2420506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) in nasal secretions.
    Shinoda M; Watanabe N; Suko T; Mogi G; Takeyama M
    Am J Rhinol; 1997; 11(3):237-41. PubMed ID: 9209598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease.
    Mandal J; Roth M; Costa L; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respiration; 2015; 90(5):357-68. PubMed ID: 26447811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P and vasoactive intestinal peptide in nasal secretions and plasma from patients with nasal allergy.
    Chaen T; Watanabe N; Mogi G; Mori K; Takeyama M
    Ann Otol Rhinol Laryngol; 1993 Jan; 102(1 Pt 1):16-21. PubMed ID: 7678375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreases in substance P and vasoactive intestinal peptide concentrations in plasma of stroke-prone spontaneously hypertensive rats.
    Mori K; Asakura S; Ogawa H; Sasagawa S; Takeyama M
    Jpn Heart J; 1993 Nov; 34(6):785-94. PubMed ID: 7513029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of eye-acupuncture therapy on serum and colonic SP and VIP contents in rats with irritable bowel syndrome].
    Wang YJ; Wang DS; Guan HQ; Wang J; Chai JY; Zhao JR; Han XW
    Zhen Ci Yan Jiu; 2010 Feb; 35(1):8-11, 26. PubMed ID: 20458899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease.
    Wallengren J; Ekman R; Möller H
    Acta Derm Venereol; 1986; 66(1):23-8. PubMed ID: 2424210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study of cerebrospinal fluid neuropeptides in patients with primary trigeminal neuralgia.
    Qin ZL; Yang LQ; Li N; Yue JN; Wu BS; Tang YZ; Guo YN; Lai GH; Ni JX
    Clin Neurol Neurosurg; 2016 Apr; 143():111-5. PubMed ID: 26918582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of changes of gastrointestinal peptides in blood and ileum of experimental spleen deficiency rats.
    Li LS; Qu RY; Wang W; Guo H
    World J Gastroenterol; 2003 Mar; 9(3):553-6. PubMed ID: 12632517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early increase and later decrease in VIP and substance P nerve fiber densities following abdominal radiotherapy: a study on the human colon.
    Höckerfelt U; Franzén L; Norrgård O; Forsgren S
    Int J Radiat Biol; 2002 Nov; 78(11):1045-53. PubMed ID: 12456292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of electroacupuncture on plasma vasoactive intestinal peptide and substance P in perennial allergic rhinitis patients].
    Li YM; Zhuang LX; Lai XS; Jiang GH
    Zhen Ci Yan Jiu; 2007 Apr; 32(2):136-8. PubMed ID: 17650661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of rheum on gastrointestinal hormones in rats with severe scald injury].
    Guo X; Tan MY; Xiong AB; Guo L
    Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):111-3. PubMed ID: 18785410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin, substance P, prolactin and vasoactive intestinal peptide levels in serum and cerebrospinal fluid of children with seizure disorders.
    Ko FJ; Chiang CH; Liu WJ; Chiang W
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Aug; 7(8):391-7. PubMed ID: 1714968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P and vasoactive intestinal peptide in rat small-bowel isografts.
    Tomita R; Fujisaki S; Park E; Ikeda T; Koshinaga T
    Am J Surg; 2005 Jan; 189(1):63-70. PubMed ID: 15701495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Neuropeptide Vasoactive Intestinal Peptide Levels in Serum are Inversely Related to Disease Severity of Postmenopausal Osteoporosis: A Cross-Sectional Study.
    Wang W; Wang ZP; Huang CY; Chen YD; Yao WF; Shi BM
    Genet Test Mol Biomarkers; 2019 Jul; 23(7):480-486. PubMed ID: 31157986
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of vasoactive intestinal peptide and substance P in the human pyloric sphincter.
    Tomita R
    Hepatogastroenterology; 2009; 56(94-95):1403-6. PubMed ID: 19950799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of substance P and vasoactive intestinal peptide on interferon-gamma and interleukin-4 production in severe atopic dermatitis.
    Kang H; Byun DG; Kim JW
    Ann Allergy Asthma Immunol; 2000 Sep; 85(3):227-32. PubMed ID: 11030278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P and vasoactive intestinal peptide levels in middle ear effusions of children.
    Eyigor H; Osma U; Yilmaz MD; Eyigor M; Gultekin M; Erin N
    Acta Otolaryngol; 2012 Oct; 132(10):1036-41. PubMed ID: 22691066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.